If you're planning on getting a Covid-19 booster this fall, you could be faced with a hefty bill — even if you have insurance ...

Imagine a world without COVID-19 vaccines: a terrifying reality of endless variants, overwhelmed hospitals, and economies in ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

All of which brings us to May 2020, when the federal government tasked the pharmaceutical industry with producing COVID ...

Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...

Robert F. Kennedy, Jr., the new Secretary of the U.S. Department of Health and Human Services (HHS), recently announced that ...

The PMCPA also agreed with the complainant that Pfizer had not taken all possible steps to avoid similar breaches in its ...

A new COVID variant NB.1.8.1 is spreading in United States. Health officials are monitoring its impact. The variant is more ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll need to take.

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...